-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target

Benzinga·03/31/2026 14:12:11
Listen to the news
Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $52 price target.